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Abstract
Background: Systematic reviews are important for decision makers. They offer many potential benefits but are
often written in technical language, are too long, and do not contain contextual details which make them hard to
use for decision-making. There are many organizations that develop and disseminate derivative products, such as
evidence summaries, from systematic reviews for different populations or subsets of decision makers. This systematic
review aimed to (1) assess the effectiveness of evidence summaries on policymakers’ use of the evidence and (2)
identify the most effective summary components for increasing policymakers’ use of the evidence. We present an
overview of the available evidence on systematic review derivative products.
Methods: We included studies of policymakers at all levels as well as health system managers. We included studies
examining any type of “evidence summary,” “policy brief,” or other products derived from systematic reviews that
presented evidence in a summarized form. The primary outcomes were the (1) use of systematic review summaries
in decision-making (e.g., self-reported use of the evidence in policymaking and decision-making) and (2) policymakers’
understanding, knowledge, and/or beliefs (e.g., changes in knowledge scores about the topic included in the
summary). We also assessed perceived relevance, credibility, usefulness, understandability, and desirability (e.g.,
format) of the summaries.
Results: Our database search combined with our gray literature search yielded 10,113 references after removal of
duplicates. From these, 54 were reviewed in full text, and we included six studies (reported in seven papers) as well as
protocols from two ongoing studies. Two studies assessed the use of evidence summaries in decision-making and
found little to no difference in effect. There was also little to no difference in effect for knowledge, understanding or
beliefs (four studies), and perceived usefulness or usability (three studies). Summary of findings tables and graded entry
summaries were perceived as slightly easier to understand compared to complete systematic reviews. Two studies
assessed formatting changes and found that for summary of findings tables, certain elements, such as reporting study
event rates and absolute differences, were preferred as well as avoiding the use of footnotes.
Conclusions: Evidence summaries are likely easier to understand than complete systematic reviews. However, their
ability to increase the use of systematic review evidence in policymaking is unclear.
Trial registration: The protocol was published in the journal Systematic Reviews (2015;4:122)
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Background
Policymakers are increasingly utilizing systematic re-
views for decision-making [1–4]. The shift from single
studies has occurred because systematic reviews offer
additional benefits to policymakers, such as having
lower risk of bias than other studies and offering more
confidence in results than single studies [2]. However,
since systematic reviews are often written using tech-
nical language, lack important contextual information,
and can be quite long, research groups and organiza-
tions have begun creating summaries of the evidence
[4, 5]. A needs assessment conducted by Evidence Aid
found that while complete systematic reviews were per-
ceived to be useful for workers “on the ground” (i.e.,
NGOs, health care providers), summaries containing
contextual information were considered helpful for
decision-making about the applicability of the findings
to their local setting [6].
There are several organizations that develop and dis-
seminate evidence summaries for different populations
or subsets of decision makers. For example, within the
Cochrane Collaboration, the Evidence Aid Project was
developed in response to the 2004 Indian Ocean Tsunami
as a means of providing decision makers and health
practitioners on the ground with summaries of the best
available evidence needed to respond to emergencies
and natural disasters [6].
SUPPORT summaries were developed for policy-
makers in low- and middle-income countries (LMICs)
making decisions about maternal and child health pro-
grams and interventions (http://supportsummaries.org/).
Health Systems Evidence provides a one-stop shop for
systematic reviews related to health systems including
policy briefs for policymakers and other stakeholders
(www.healthsystemsevidence.org/). Other examples in-
clude Cochrane Summaries (http://www.cochrane.org/
evidence), Communicate to vaccinate (COMMVAC)
(http://www.commvac.com), and Rx for change
(https://www.cadth.ca/rx-change). A document ana-
lysis conducted by Adam et al. identified 16 organiza-
tions involved in the production of summaries for
policymakers in LMICs [7]. These summaries are
identified using many different terms including evi-
dence summaries, policy briefs, briefing papers, brief-
ing notes, evidence briefs, abstracts, summary of
findings, and plain language summaries [7] but often
contain summarized evidence from systematic reviews.
They are intended to assist decision makers in under-
standing the evidence and encourage its use in their
decision-making. These user-friendly formats highlight
the policy-relevant information and allow policy-
makers to quickly scan the document for relevance
[2, 8]. The various products have some differences.
For example, abstracts, evidence summaries, and
summary of findings tables summarize evidence from
a single systematic review while policy briefs utilize
evidence from one or more systematic reviews and
may use additional sources to provide contextual or
economic information [7].
Evidence on the usefulness and effectiveness of sys-
tematic review derivatives is lacking. Previously con-
ducted systematic reviews have looked at interventions
to increase the use of systematic reviews among deci-
sion makers; however, these have focused on the use of
complete systematic reviews in decision-making, and
none focused specifically on derivatives of systematic
reviews. For example, one systematic review examined
the effectiveness of interventions for improving the use
of systematic reviews in decision-making by health sys-
tem managers, policymakers, and clinicians [9]. This re-
view included eight studies, and the authors concluded
that information provided as a single, clear message
may improve evidence-based practice, but increasing
awareness and knowledge of systematic review evidence
might require a multi-faceted intervention. Similarly,
another systematic review assessed interventions en-
couraging the use of systematic reviews by health policy-
makers and managers [10]. Four studies were included,
and the authors concluded that future research should
identify how systematic reviews are accessed and the
formats used to present the information. A systematic
review by Wallace et al. found that the barriers, facilita-
tors, and interventions that impact systematic review
uptake found that a description of benefits as well as
harms and costs and the use of a graded entry approach
(in which evidence is available as a one-page summary,
three-page summary, or 25-page full report) facilitated
systematic review use by policymakers [11]. Similarly, a
systematic review by Oliver et al. also assessed barriers
and facilitators to the use of research by policymakers;
they found that access to high-quality, relevant research
as well as collaboration between researchers and policy-
makers were the most important factors for increasing
research use [12].
This review aimed to assess the effectiveness of sys-
tematic review summaries on increasing policymakers’
use of systematic review evidence and to identify the
components or features of these summaries that are most
effective [13]. We present an overview of the available
evidence on systematic review derivative products.
Objectives
The objectives of this review were to (1) assess the ef-
fectiveness of evidence summaries on policy-makers’
use of the evidence and (2) identify the most effective
summary components for increasing policy-makers’ use
of the evidence.
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Methods
Review protocol
We developed and published an a priori protocol for this
systematic review [13].
Searches
Information specialists (APA, HC) developed and trans-
lated the search strategy using the PRESS Guideline [14].
Electronic searches
We used the search strategy developed by Perrier et al.
and Murthy et al. for their systematic reviews of interven-
tions to encourage the use of systematic reviews by health
managers and policymakers to inform our search [9, 10].
We expanded the Perrier search by including additional
databases, as suggested by John Eyres, of the International
Initiative for Impact Evaluation (3ie) and the Campbell
International Development Review Group. These included
Global Health Library (from WHO), Popline, Africa-wide,
Public Affairs Information Service, Worldwide Political
Science Abstracts, Web of Science, and DfiD (Research
for Development Database). The search strategies were
translated using each database platform’s command
language and appropriate search fields. Both controlled
vocabulary terms and text words were used for the search
concepts of policymaking, evidence synthesis, systematic
reviews, knowledge translation, and dissemination. No
date restrictions were used. The complete MEDLINE
search strategy is available in Additional file 1.
Searching other resources
We identified and searched websites of research groups
and organizations which produce evidence summaries
building on the list of organizations identified by Adam
et al. [7]. We searched for unpublished studies evaluat-
ing the effectiveness of the systematic review derivatives
in increasing policymakers’ understanding (e.g., Health
Systems Evidence, the Canadian Agency For Drugs And
Technologies In Health, SUPPORT summaries). A
complete list of gray literature sources is provided in
Additional file 2.
We also checked the reference lists of included studies
and related systematic reviews to identify additional
studies. We contacted researchers to identify ongoing
and completed/published work. The results of the search
are reported in Fig. 1.
Fig. 1 PRISMA flow diagram
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Study inclusion and exclusion criteria
Eligible studies included randomised controlled trials
(RCTs), non-randomised controlled trials (NRCTs), con-
trolled before-after (CBA) studies, and interrupted time
series (ITS) studies.
We included studies whose participants were health
policymakers at all levels. We defined policymakers as
health ministers and their political staff, civil servants,
health system managers, and health system stakeholders
as civil society groups, patient groups, professional asso-
ciations, non-governmental organizations, donors, and
international agencies [15]. We included populations in-
volved in the development of clinical practice guidelines.
To be included, the population had to be responsible for
decision-making on behalf of a large jurisdiction or
organization, and we did not include studies related to
decision-making for an individual person or patient [15].
We included studies of interventions examining any
type of “friendly front end”, “evidence summary”, or
“policy brief” or other products derived from systematic
reviews or guidelines based on systematic reviews that
present evidence in a summarized form to policy-makers
and health system managers. Interventions had to in-
clude a summary of a systematic review and be actively
“pushed” to target users. We included any comparisons
including active comparators (e.g., other summary for-
mats) or no intervention.
Primary outcomes
1. Use of systematic review derivative product in
decision-making (e.g., self-reported use of the
evidence in policymaking, decision-making, as well
as self-reported access of research, appraisal of
research, or commissioning of further research within
the decision-making process [16]). We included any
type of use including instrumental use of research in
decision-making (e.g., direct use of research), as well
as conceptual use (e.g., using research to gain an
understanding of a problem or intervention), and
symbolic use (e.g., using research to confirm a
policy/program already implemented) [17]
2. Understanding, knowledge, and/or beliefs (e.g.,
changes in knowledge scores about the topic
included in the summary)
Secondary outcomes
 Perceived relevance of systematic review summaries
 Perceived credibility of the summaries
 Perceived usefulness and usability of systematic
review summaries
o Perceptions and attitudes regarding the specific
components of the summaries and their usefulness
 Understandability of summaries
 Desirability of summaries (e.g., layout, selection of
images, etc.) [5]
Since some studies may use different terms to describe
these outcomes, our team assessed each outcome and
categorized them according to the above list.
Two reviewers independently screened titles and
abstracts to identify relevant studies meeting the pre-
specified inclusion criteria. The full text of each poten-
tially included study was then screened independently
by two authors.
Potential effect modifiers and reasons for heterogeneity
Meta-analysis was not possible, but if it had been, we
planned to explore heterogeneity using forest plots and
the I2 statistic according to guidance of the Cochrane
Handbook for Systematic Reviews of Interventions [18].
We were also thus unable to conduct planned meta-
regression to assess the role of mediating factors, such
as target audience of summary (e.g., focused on specific
local context, generic summary), type of decision maker
(e.g., federal policy-maker versus hospital administrator),
and components of friendly front end (e.g., bulleted list,
text, summary of findings table, causal chain).
Study quality assessment
The methodological quality was assessed using the risk
of bias tool from the Cochrane Handbook for random-
ized trials. If we had identified eligible ITS, CBA, or
NRS, we planned to use the Effective Practice and
Organization of Care (EPOC) Review Group criteria
for ITS and CBA studies [18, 19] and Risk Of Bias In
Non-randomized Studies-of Interventions (ROBINS-I)
[20, 21].
We used the Grading of Recommendations Assess-
ment, Development, and Evaluation (GRADE) approach
to assess the quality of evidence for the outcomes
reported in this review [22].
Data extraction strategy
The data extraction form was pre-tested, and included
factors related to the population, intervention, compari-
son, and outcomes. Data extraction was completed by
two authors independently using a structured Excel
sheet. Disagreements on extractions were resolved by
discussion and with a third member of the research
team when necessary. The complete list of data extrac-
tion items has been reported elsewhere [13].
Data synthesis and presentation
Since it was not possible to combine the studies, we
have presented the results for each study separately. We
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planned to conduct sensitivity analyses to assess the ef-
fects of incorporating these corrected analyses in our
analysis. However, since we did not conduct a meta-
analysis, this was not possible. We contacted the corre-
sponding author of studies by email to ask for clarifica-
tion on missing data and to ask for complete study
results for eligible protocols.
Results
Review statistics
Results of the search
The search strategy yielded 11,733 references (10,113
after removal of duplicates). Figure 1 depicts the results
of the search and screening. During the title and abstract
screening process, we excluded the 10,059 references for
failing to meet one or more of our inclusion criteria.
The remaining 50 references were reviewed as full text
plus three additional references identified through ref-
erence list checking and one additional reference iden-
tified through gray literature searching. We excluded
45 studies that did not meet our eligibility criteria (see
Additional file 3). We included six completed RCTs (re-
ported in seven articles) in this review [23–28]. The
characteristics of the included studies are summarized
in Table 1.
The completed studies recruited participants from
Canada (n = 1), Kenya (n = 1), USA (n = 1), internation-
ally unspecified countries (46% from high-income coun-
tries) (n = 1), and countries in Europe, North America,
South America, Africa, and Asia (n = 1) [23, 25–27, 29,
30]. One study did not report the participants’ country
[28]. Additionally, we identified two protocols for eligible
studies: one RCT [31] and one CBA [32]. These ongoing
studies will be conducted in Canada (n = 1) and UK
(n = 1) [31, 32]. The details of these studies are pre-
sented in Table 2.
Description of included studies
Details of the different evidence summary formats are
reported in Table 3. Briefly, two studies assessed policy
briefs [23, 26]; one assessed an “evidence summary” [25];
two assessed different formats of summary of findings
tables, which are distinct table formats presenting the
main findings of the review (absolute and relative effects
for each important outcome) and quality of the evidence
[28, 30]; and one compared an SOF table alone to a
summary of findings table as part of a “graded entry”
evidence summary (a short one-page summary, then a
narrative report, followed by access to the complete
systematic review) [27]. Two studies assessed evidence
summaries which included recommendations for pro-
grams or policies [23, 25], while the others did not spe-
cify whether recommendations were provided within
the summary [26–28].
Carrasco-Labra et al. compared a standard format
summary of findings table to a new format that pre-
sented some of the data in a different way as well as
provided supplementary data [30]. All the other in-
cluded studies tested evidence summary formats using
multiple arms. Brownson et al. compared four versions
of a policy brief: a state-level, data-focused brief; a
local-level, data-focused brief; a story-focused brief with
a state-level data; and a story-focused brief with a local-
level data [23].
Dobbins et al. had three groups. The first had access
to the online database, the second received targeted,
tailored messages in addition to access to an online
database, and the third group received the same inter-
vention as the second group plus access to a full-time
knowledge broker [25].
Masset et al. and the companion paper by Beynon
et al. assessed three versions of a policy brief. The first
was the standard policy brief, the second was the same
policy brief with an additional commentary by a sector
expert (the Director of the institution who conducted
the review), and the third was the same except the
commentary was attributed to an unnamed research
fellow [26, 29].
The study by Opiyo et al. compared a systematic re-
view alone to a systematic review with a summary of
findings table and a graded entry format that included
a short interpretation of the main findings and con-
clusions (with a summary of findings table), a context-
ually framed narrative report, and the full systematic
review [27].
Finally, the study by Vandvik et al. compared two ver-
sions of summary of findings tables with or without four
formatting modifications (the placement of additional
information, the placement of the overall rating for qual-
ity of evidence, the study event rates, and the absolute
risk differences) [28].
Study quality assessment
The summary of the Risk of Bias assessments is pre-
sented in Fig. 2. Two studies were assessed as low risk
of bias for random sequence generation [25, 30], and
the others were assessed as unclear [23, 26–28]. For
allocation concealment, four studies were assessed as
unclear [23, 25–27, 29] and two studies assessed as low
risk of bias [28, 30]. Baseline outcome measurements
were similar and therefore low risk of bias in two stud-
ies [25, 26, 29] and unclear in four [23, 27, 28, 30].
Baseline characteristics were also similar in two studies
[23, 26, 29] and unclear in the others [25, 27, 28, 30].
Incomplete outcome data was assessed as low risk of
bias for four studies [25, 27, 28, 30] but high for two
studies [23, 26, 29]. These two studies had very high
rates of attrition; Brownson et al. had an overall
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Table 1 Characteristics of included studies
Study ID Methods Participants Intervention description Outcomes
Brownson
2011 [23]
RCT Legislative staff members (e.g.,
committee staff), state legislators,
and executive branch administrators
(e.g., division directors, program heads)
4 different policy briefs on
mammography screening to reduce
breast cancer mortality
- Data-focused brief with state-level data
- Data-focused brief with local-level data
- Story-focused brief with state-level data
- Story-focused brief with local-level data
Each participant was emailed 1 of the 4
briefs.
Self-reported understandability
(using 3 measures assessing whether the
information was presented clearly in an
attractive way and held the reader’s
attention) and credibility (2 measures that
assessed whether the information in the




RCT Health care professionals, guideline
developers and researchers that use
and/or develop systematic reviews
An alternate summary of findings table
was compared against the current format
- Alternate format provides options to
display the same data in a different
way or to provide supplementary data
to the current format
Self-reported understanding assessed with
7 multiple choice questions (5 response
options). Self-reported accessibility of
information assessed with 3 self-reported
domains (how easy it is to find critical
information, how easy it is to understand
the information, whether the information
is presented in a useful way for decision-
making. Satisfaction measured by asking
which about satisfaction with the different
formatting elements. Preference assessed
using a 7-point Likert scale for the 2 tables
Dobbins
2009 [25]
RCT Front line staff, managers, directors,
coordinators, and others from public
health departments in Canada (those
directly responsible for making
program decisions related to healthy
body weight promotion in children)
1st group (control)
- Access to health-evidence.ca and
received an email about access to
this resource
2nd group
- Received tailored, targeted
messages—7 emails with titles of 7
high-quality SRs related to health body
weight promotion in children and links
to full text, abstract, and summary, plus
access to health-evidence.ca
3rd group
- Same intervention as the 2nd group
plus access to a full-time knowledge
broker who was available to ensuring
relevant research, was provided to the
decision makers in a way that was
useful, helped them to develop skills
for evidence-informed decision-making,
and translating the evidence
Self-reported global evidence-informed
decision-making (participants were asked
to report the extent to which research
evidence was considered in a recent
program planning decision within the
previous 12 months) related to healthy
body weight promotion and public health
policies and programs measured by the
sum of actual strategies, policies, and/or
interventions for healthy body weight





RCT Individuals who normally read policy
briefs related to international
development, e.g., employed in
academia, NGOs, and international
aid organizations, some self-reported
influence on policy decisions and
therefore considered policymakers
3 versions of a policy brief summarizing
the results of a SR
- One group received a standard policy
brief
- 2nd group received a policy brief with
director’s commentary
- 3rd group received the policy brief
with unnamed research fellow’s
commentary
Beliefs about the effectiveness of and
strength of the evidence for the
interventions included in the briefs
Opiyo
2013 [27]
RCT Panel of healthcare professionals with
roles in neonatal and pediatric policy
and care in Kenya
3 intervention packages
- Pack A contained a systematic review
alone
- Pack B included systematic reviews
with summary of findings tables
- Pack C received an evidence summary
with a graded entry format
Self-reported understanding of the
summary content measured by the
proportion of correct responses to clinical
questions relevant to the effects of the
intervention.
Value and accessibility (usefulness and
usability) of the evidence was assessed
using a 3- or 5-point scale
Vandvik
2012 [28]
RCT All panelists for the antithrombotic
therapy and prevention of thrombosis,
American College of Chest Physicians
2 formats of the evidence profile that
differed by 4 features
- Placement of additional information
- Placement of overall quality of
evidence
- Study event rates
- Absolute risk differences
User preferences for specific formatting
options and the overall format of the table
were assessed using a 7-point Likert scale
Comprehension of key findings was
assessed with multiple choice questions
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response rate of 35%, and the Masset study had 50% at-
trition between the baseline and first follow-up [23].
Prevention of knowledge of allocated interventions was
assessed as unclear for four of the studies [23, 25–27, 29].
One study reported that panelists, data collection, and
data analysis were blinded [28], and one reported that
allocation was done in real time when the survey was
completed, and these were therefore assessed as low
risk of bias [30]. Adequate protection from contamin-
ation was assessed as unclear for four studies. The
Dobbins study included public health departments
from across Canada, and therefore, little risk of con-
tamination was expected [25], and Carrasco-Labra
et al. reported that allocation was done in real time
when completing the survey leaving little risk of con-
tamination [30]. All studies were assessed as low risk
of bias for selective outcome reporting.
Most outcomes were assessed as moderate certainty of
evidence using GRADE [22]. The reasons for downgrad-
ing the evidence were due to unclear risk of bias or small
sample sizes. Perceived desirability of the summaries was
assessed as high certainty of evidence. The assessments
are included in Table 4.
Evidence of effectiveness
We generated a summary of findings table for this re-
view (Table 4). This is a narrative summary of all studies
assessing a particular outcome domain, pooled across
different policy brief formats.
Primary outcomes
Use of summaries in decision-making Two studies
assessed self-reported use of summaries in decision-
making. First, Dobbins et al. assessed instrumental use;
Table 1 Characteristics of included studies (Continued)
Each group received 1 of 4 emails with
similar text but different links allowing
download of the evidence profile
Accessibility of the information for quality
of evidence and relative and absolute
effects was assessed using 3
domains: easy to find, easy to understand,
and helpful in making recommendation
using a 7-point scale
Time needed to comprehend information
about quality assessment and key findings
was assessed by asking participants to
record the time before and after answering
questions testing comprehension
Table 2 Characteristics of ongoing studies
Study ID Methods Participants Intervention description Outcomes
Wilson
2011 [31]
RCT Decision makers (programs,
services, advocacy) from
community-based HIV/AIDS
organizations in Canada affiliated
with the Canadian AIDS Society
and from relevant provincial
HIV/AIDS networks
At baseline, all participants will receive the “self-serve”
evidence service (includes a listing of relevant systematic
reviews, links to PubMed records, and worksheets to help
find and use research evidence). During the intervention,
one group will receive the “full-serve” version of SHARE
(Synthesized HIV/AIDS Research Evidence) which includes
access to a database of HIV systematic reviews, emailed
updates, access to user-friendly summaries, links to scientific
abstracts, peer relevance assessments (indicating how useful
the information is), as well as an interface for comments
in the records, plus links to the full text, and access to
worksheets to help find and use evidence. The control
group will continue to receive the self-serve evidence
service. During the final 2-month period, both groups will
receive the full-serve version of SHARE
The primary outcome measure
will be the mean number of
logins/month/organization.
The secondary outcome will
be intention to use research
evidence (measured with a
survey administered to one




CBA Clinical Commissioning Groups:
governing body and executive
members, clinical leads, and
any other individuals deemed
as being involved in
commissioning decision-
making processes
3 arms: (1) consulting plus responsive push of tailored
evidence (access to an evidence briefing service provided by
the Centre for Reviews and Dissemination (CRD) plus advice
and support via phone, email, face-to-face; monthly check
in to discuss further evidence needs; issues around use of
evidence; alert team to new SRs, and other synthesized
evidence relevant to priorities); (2) consulting plus an
unsolicited push of non-tailored evidence (access to
intervention 1 without tailored evidence briefings and
instead just evidence briefings without contextual
information); or (3) “standard” service (CRD will disseminate
evidence briefings generated in intervention 1 and any
other non-tailored briefings produced by CRD over the
intervention period)
Primary outcome: change at
12 months from baseline of a
CCGs ability to acquire, assess,
adapt, and apply research
evidence to support decision-
making. Secondary outcomes
will measure individuals’
intentions to use research
evidence in decision-making
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Table 3 Evidence summary formats and results


















Front cover varied according to story-
versus data-driven, color printed (included
data or story), 3rd and 4th pages are the
same across all 4 briefs, data-driven briefs
contained 2 statements with percentages
related to mammography screening, story-
driven had 2 personal stories related to
mammography, all briefs had data about
uninsured women, women not up to date
on mammograms, breast cancer mortality
compared to other causes, benefits of
mammograms, and recommendations
The briefs were considered
understandable and credible (mean
ratings ranged from 4.3 to 4.5 on 5.0
Likert scale). Likelihood of using the
brief was different by study condition
for staff members (p = 0.041) and
legislators (p = 0.018). Staff members
found the story-focused brief with
state-level data the most useful.
Legislators found the data-focused brief






Table Emailed link to
online survey
The new format of summary of findings
table moved the number of participants
and studies to the outcomes column,
quality of evidence was presented with the
main reasons for downgrading, “footnotes”
was changed to “explanations”, baseline risk
and corresponding risk were expressed as
percentages, column presenting absolute
risk reduction (risk difference) or mean
difference, no comments column, addition
of “what happens” column, no description
of the GRADE evidence definitions
Participants with the new summary of
findings table format had higher
proportion of correct answers for
almost all questions. The new format
was more accessible (easier to
understand information about the
effects (MD 0.4, SE 0.19); and displayed
results in a way that was more helpful
for decision-making (MD 0.5 SE 0.18);
overall, participants preferred the new







Short summary including key findings and
recommendations
The post-intervention change in Global
Evidence-Informed Decision-making
was 0.74 (95% CI 0.26–1.22) for the
group receiving only access to
healthevidence.ca; –0.42 (–1.10, 0.26)
for the group receiving tailored,
targeted emails; and –0.09 (–0.78, 0.60)
for the knowledge broker group.
The changes in health policies and
programs (HPP) after the intervention
were –0.28 (–1.20, 0.65) for the group
receiving only access to the
healthevidence.ca website; 1.67 (0.37,
2.97) for the group receiving tailored,
targeted messages; and –0.19 (–1.50,
1.12) for the group with access to a
knowledge brokers.
The tailored, targeted messages are
more effective than the knowledge
broker intervention or access to
www.health-evidence.ca in organizations




Policy brief Text, colored
leaflet
Email Introduction to the problem, description
of methodology, conclusions, and policy
implications, 2 versions had expert
commentary
Respondents with stronger beliefs
about the agricultural interventions at
baseline rated the policy brief more
favourably
The policy brief was less effective in
changing respondents’ ratings of the
strength of the evidence and








Text, tables Email Summary of findings table
Graded entry format included a summary
and interpretation of main findings and
conclusions, a contextually framed narrative
report, and summary of findings table
No differences between groups in the
odds of correct responses to key clinical
questions
Both packs B and C improved
understanding. Pack C compared to
pack A was associated with a
significantly higher mean “value and
accessibility” score. Pack C compared to
pack A was associated with a 1.5 higher
odds of judgments about the quality of
evidence being clear and accessible.
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the change in global evidence-informed decision-making
(EIDM) (defined as the extent to which research
evidence was considered in a recent decision) after
18 months. The authors found that the intervention had
no significant effect on EIDM. This study also reported
on evidence-based public health policies and programs
as a measure of the actual number of strategies, policies,
and interventions for health body weight promotion
among children that were implemented by the health de-
partment. For this outcome, the group that received the
targeted, tailored messages had a significant increase in
evidence-based public health policies and programs.
The study by Brownson et al. asked policymakers how
likely they would be to use the evidence summary in
decision-making classified as conceptual use of research.
On a five-point Likert scale (where 1 is strongly disagree
and 5 is strongly agree), there was little to no difference
based on the type of policy brief (data-driven versus
story-driven) (range 3.3 to 3.4). However, there were
differences in self-reported likelihood of using the
policy brief depending on the type of policymaker. Staff
members reported being the most likely to use the
story-focused brief with state-level data (mean rating of
3.4, 95% confidence interval (CI) 3.0 to 3.9) and the
least likely to use the data-focused brief with state-level
data (2.5, 95% CI 2.0 to 3.0). Legislators reported being
the most likely to use the data-focused brief with state-
level data (4.1, 95% CI 3.6 to 4.6) and the least likely to
use the story-focused brief with state-level data (3.1,
95% CI 2.6 to 3.6) [23].
Understanding, knowledge, and/or beliefs Carrasco-
Labra et al. found that respondents receiving the new
summary of findings format had a higher proportion of
correct answers for almost all questions. These included
the ability to interpret footnotes (risk difference (RD) 7%,
Table 3 Evidence summary formats and results (Continued)
More than half of participants preferred
narrative report formats to the full
version of the SR (53% versus 25%). A
higher respondent percentage (60%)
found SRs to be more difficult to read
compared to narrative reports, but some
(17%) said that SRs were easy to read.
About half of the participants (51%)
found SRs to be easier to read compared





Table Email Tables presented outcomes, number of
participants, summary of findings, and
quality assessment using GRADE
Participants liked presentation of study
event rates over no study event rates,
absolute risk differences over absolute
risks, and additional information in
table cells over footnotes. Panelists
presented with time frame information
in the tables, and not only in footnotes,
were more likely to properly answer
questions regarding time frame and
those presented with risk differences,
and not absolute risks were more likely
to rightly interpret confidence intervals
for absolute effects. Information was
considered easy to find and to
comprehend and also helpful in
making recommendations regardless
of table format
Fig. 2 Risk of bias
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p = 0.18), ability to determine risk difference (RD 63%,
p = <0.001), understanding of quality of evidence and treat-
ment effect (RD 62%, p = <0.001), understanding of the
quality of evidence (RD 7%, p = 0.06), and ability to quan-
tify risk (RD 6%, p = 0.06) [30]. However, for one question,
the ability to relate the number of participants and studies
to outcomes, the group receiving the standard summary of
findings scored slightly higher (RD −3%, p = 1.0).
The Masset study examined changes in beliefs about
the effectiveness of the intervention as well as the
strength of the evidence included in the policy briefs.
The authors found that the policy brief increased the
number of participants who had an opinion about the
strength of the evidence (e.g., those who did not have an
opinion at baseline formed an opinion based on the pol-
icy brief ) but was less effective in changing participants’
ratings of the strength of the evidence or the effective-
ness of the intervention [26]. The policy brief did not
change the opinions of those who had an opinion at
baseline about the evidence and effectiveness.
The Opiyo study found little to no difference between
the interventions for the odds of correct responses and
questions about the intervention (adjusted odds ratio
(OR) for summary of findings table compared to system-
atic review alone was 0.59, 95% CI 0.32 to 1.07, and for
graded entry format compared to systematic review
alone OR 0.66, 95% CI 0.36 to 1.21); however, both of
these indicated that the odds of correct responses were
higher for the groups who received an evidence summary
or summary of findings [27]. However, when comparing
groups of participants, both the summary of findings
tables and the graded entry formats slightly improved un-
derstanding for policymakers (summary of findings table
compared to systematic review alone adjusted OR 1.5,
95% CI 0.15 to 15.15 and for graded entry format com-
pared to systematic review alone, 1.5 (0.64 to 3.54)) [27].
Table 4 Summary of findings table
Evidence summaries to increase policymakers’ use of systematic review evidence
Patient or population: policymakers and health system managers
Settings:
Intervention: evidence summaries based on systematic review
Comparison: any comparison






Use of systematic review
evidence in decision-making
Little to no difference in effect on evidence-informed decision-making when compared
to access to a knowledge broker or online registry of research [25]
Little to no difference in effect on self-reported likelihood of using data-driven versus





One study found little to no effect on understanding of information when provided in
different summary of findings table formats [28] while the other found that those
provided with a new version of the summary of findings table had consistently higher
proportions of correct answers assessing understanding of key findings provided in the
table [30]
Little to no effect in understanding of information for a graded entry format compared to
an summary of findings table or systematic review alone [27]
Little to no effect on changing participants’ beliefs about the strength of the evidence for
those who already had beliefs but increased the number of participants who had beliefs





Little to no difference in perceived credibility for different versions of the policy brief






The graded entry format was rated higher than the systematic review alone, and there
was little to no difference between the ratings for the summary of findings table and the
systematic review alone [27]
Different summary of findings table formats had little to no effect in one study [28], but a
new summary of findings format was found to be more accessible than the standard





All formats of the policy brief were reported as easy to understand [23]
Graded entry formats were easier to understand the summary of findings tables or





Alternate versions of the summary of findings were preferred [28, 30] 378 (2) ⊕⊕⊕⊕
High
GRADE working group grades of evidence, High quality further research is very unlikely to change our confidence in the estimate of effect, Moderate quality
further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate, Low quality further research is
very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate, Very low quality we are very uncertain
about the estimate
aUnclear ROB
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Finally, Vandvik et al. reported that there was little to
no difference in participants’ understanding of informa-
tion in the different table formats for most items (range
80 to 97% for table A compared to 69 to 92% for table
B, p values from 0.26 to 0.86) However, those with
table A had higher scores for two items: time period
for risk estimates (58% compared to 11%, p < 0.0001)
and the range in which the effect may lie (95% versus
54%, p < 0.0001) [28].
Secondary outcomes
Credibility of the summaries Brownson et al. reported
little to no differences in credibility between the different
intervention formats. The mean scores for perceived
credibility ranged from 4.4 to 4.5 on a five-point Likert
scale [23]. For different policymaker groups, there were
also little to no differences with mean scores ranging
from 4.2 to 4.5 for staff members, 4.3 to 4.7 for legisla-
tors, and 4.3 to 4.6 for executives [23].
The Masset study assessed how convincing the policy
brief was, how robust the methodology was, and how
strong the evidence was. Participants who had stronger
beliefs about the evidence at baseline rated the policy
brief more favorably [26].
Perceived usefulness and usability of the summaries
The Carrasco-Labra study reported that the new sum-
mary of findings format was more accessible than the
standard format [30]. This was assessed by asking re-
spondents about their ease of finding the information
about the effects (MD 0.4, SE 0.19, p = 0.04) and ease of
understanding the information (MD 0.5, SE 0.2, p =
0.011). The respondents also reported that the new for-
mat displayed results in a way that was more helpful
for decision-making (MD 0.5, SE 0.18, p = 0.011).
Opiyo et al. measured this outcome by assessing the
“value and accessibility” of each intervention. The graded
entry format received a higher mean score than the sys-
tematic review alone (adjusted mean difference (MD)
0.52 (95% CI 0.06 to 0.99). There was little to no differ-
ence in effect when comparing the summary of findings
table and the systematic review alone (MD −0.11, 95%
CI −0.71 to 0.48) [27].
Vandvik et al. reported that accessibility of information
for quality of evidence as well as absolute and relative
effects was rated similarly with no significant differ-
ences between groups [28]. Only pooled results were
presented.
Perceived understandability of the summaries All the
groups in the Brownson et al. study reported that the
summaries were easy to understand [23]. The mean
ratings ranged from 4.3 to 4.4 on a five-point Likert
scale. For the different policymaker groups, there was
little to no difference with mean scores ranging from
4.3 to 4.5 for staff members and legislators and 4.1 to
4.4 for executives [23].
The study by Opiyo et al. reported that 60% (95% CI
48 to 73%) of the participants found systematic reviews
to be more difficult to read than the narrative reports in-
cluded in the graded entry formats. Fifty-one percent
(95% CI 38 to 63%) compared to 26% (95% CI 15 to
37%) found the systematic reviews to be easier to read
than the summary of findings tables, while 53% (95% CI
41 to 65%) compared to 25% (95% CI 14 to 36%) pre-
ferred the narrative report format (graded entry) to the
full systematic review [27].
Perceived desirability of the summaries The two stud-
ies of different summary of findings formats assessed
this outcome. One study found that participants pre-
ferred the presentation of study event rates versus not
having them (median 1, interquartile range (IQR) 1, on
1–7 scale, where 1 was strong preference for and 7 was
strong preference against), absolute risk differences versus
presentation of absolute risks (median 2, IQR 3), and hav-
ing the additional information embedded in table versus
having it as footnotes (median 1, IQR 2). No significant
differences found for the placement of the column for
overall quality of evidence (either as the final column or
before the effect size) or the overall table format (differing
by column headings and order of columns) [28].
The other study found that overall, respondents
preferred the new summary of findings format (MD
2.8, SD 1.6) [30].
None of the included studies reported on policy-
makers’ perceived relevance of the summaries.
Effect modifiers
The organizational research culture was found to influ-
ence the effect of the intervention on evidence-based
public health policies and programs in one study which
found that tailored, targeted messages were more effect-
ive than access to a database alone (healthevidence.ca)
or access to a knowledge broker when the organization
valued research evidence in decision-making [25].
The Carrasco-Labra study found that the number of
years of experience of the respondents modified the ef-
fect on understanding by more than 10% (adjusted OR
1.83; 95% CI 0.91 to 3.67) for the questions about the
ability to determine a risk difference. For the question
assessing whether respondents understand the quality
of evidence and treatment effect combined, the authors
found that years of experience, familiarity with GRADE,
and level of training modified the effect by more than
10% (adjusted OR 0.72; 95% CI 0.20 to 2.56).
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Discussion
This review has summarized the evidence on the use of
systematic review summaries in policymaking, policy-
makers’ understanding of systematic review evidence,
and different components and design features. Overall,
the results suggest that evidence summaries are likely
easier to understand than complete systematic reviews.
However, their ability to increase the use of systematic
review evidence in policymaking is unclear. Six studies
were included in this review. For our primary outcome,
the use of systematic review evidence in decision-
making, we found moderate certainty of evidence. One
study found that targeted, tailored messages increased
the number of evidence-based public health policies and
programs; however, for the two studies that assessed
effect on decision-making or likelihood of using the
summary in decision-making, there was little to no
difference between the intervention groups [23, 25]. For
the secondary outcome, understanding, knowledge, and
beliefs, there was little to no difference in effect and
moderate certainty of evidence in three of the four
studies assessing this outcome [26–28] although there
was a slight increase in understanding for summary of
findings tables and graded entry formats compared to
systematic reviews alone. The fourth study found that
those provided with an alternate version of the sum-
mary of findings had greater understanding [30]. For
perceived desirability of summaries, we found high cer-
tainty of evidence. In summary of findings tables, one
study found that the alternate version was preferred,
[30] and the other study found that certain formatting
elements were preferred such as study event rates,
absolute risk differences, and additional information
provided in the table and not in footnotes [28]. One
study found the alternate format to be more accessible
than the standard format [30]; however, the other study
assessing formatting changes found little to no differ-
ence in effect for perceived usefulness [28]. For per-
ceived usefulness and usability of the summaries, we
found low certainty of evidence. The graded entry sum-
mary was rated higher than a systematic review alone
for usability [27]. Summaries were perceived as easier
to understand than systematic reviews (moderate cer-
tainty of evidence) [23, 27]. There was little to no dif-
ference in effect for different versions of the policy brief
(data-driven versus story-driven, local- versus state-
level data; moderate certainty of evidence) for perceived
credibility of the summaries [23].
Our primary outcome, the policymakers’ use of sys-
tematic review evidence in decision-making, is challen-
ging to measure. Other studies have noted the inherent
challenges in measuring this outcome since many fac-
tors contribute to decision-making, and it is often diffi-
cult for an individual to identify which factors had a
role in their final decision [25, 33]. Instead of determin-
ing the actual use of research in decision-making, stud-
ies assessed self-reported use of research or other
outcomes, such as perceived credibility or relevance,
since these may affect the likelihood of research use in
decision-making.
Our review is limited by the indexing of studies in
this area. To address this issue, we conducted a broad
search using search strategies adapted from similar sys-
tematic review. Our search identified over 10,000 refer-
ences, but we had a low yield of included studies. The
methods used in the included studies were poorly
reported. For example, only two studies adequately
reported on random sequence generation or allocation
concealment, which means that most studies have un-
clear risk of bias.
More research is needed to determine whether evi-
dence summaries can increase the use of systematic re-
views by policymakers and health system managers. We
identified two protocols for ongoing studies which are
promising as the results of these studies will enhance
the available evidence about the effectiveness of evidence
summaries [31, 32]. We also identified other relevant
studies assessing the effectiveness of systematic review
derivatives that did not use an eligible study design (e.g.,
used interviews or other methods without a control
group) [5, 21]. One of these studies was intended to be a
RCT and process evaluation but was not eligible for our
review because poor recruitment (only 15% of the
planned sample) resulted in the termination of the trial
[21]. This demonstrates the difficulty with recruiting
these types of participants. Recruitment for the process
evaluation remained low, and the authors noted that
those included are likely those already more interested
in using systematic review derivatives [21]. The authors
noted that for future RCTs, recruitment may be more
successful achieved from randomizing divisions versus
individuals since the nature of policymaking is quite
complex and often not completed at the individual level.
Additionally, we identified other studies that were not
focused on policymakers but rather, clinicians [34, 35]
or the public [36]. These studies demonstrated that
evidence summaries can improve understanding of re-
search evidence within these populations; however, use
of evidence in decision-making was not assessed.
It is important to note that only two of the included
studies compared the evidence summary to a full
systematic review or access to a database of systematic
reviews. The others compared different versions of
evidence summaries and, in general, found little to no
differences in the effects. Had these studies included
systematic reviews as a control group, the results may
be different. Additional research on the use of evidence
summaries derived from systematic reviews is needed.
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A previously conducted systematic review identified
poor access to high-quality and relevant research as a
barrier to the use of research evidence by policymakers
[12]. Evidence summaries can address this barrier by in-
creasing access to systematic review evidence provided
that policymakers are aware that these products are
available. Our review has not identified the best way to
disseminate these products although one study found
that targeted, tailored messages improved research use
by the policymakers [25]. Future developers of system-
atic review products should collaborate with the policy-
makers to ensure that their summaries are relevant to
those making decisions in practice [12]. Future studies
should include an assessment of delivery strategies since
the effectiveness of the systematic review derivative
product in practice will be impacted by the policy-
makers’ knowledge of and access to the summaries
themselves. Our included studies suggest that evidence
summaries have a small effect on improving knowledge
and understanding and should be created. However, we
have very little evidence to inform the design of evidence
summaries since we only found a handful of different
formats (none the same), and there was little to no dif-
ference between formats when compared directly.
The interventions assessed in the studies included in
our review are quite diverse with a variety of outcome
measures. We included a broad range of interventions to
provide an overview of the evidence on systematic review
derivative products. These products have important differ-
ences in design and source material. For example, a policy
brief includes evidence from one or more systematic re-
views and includes information from additional sources
[4, 7], whereas a summary of findings table reports results
for a single systematic review. We chose to include all sys-
tematic review derivative products since there are limited
studies on a single product type. We recognize that this
creates a challenge for interpreting the results since the
interventions were quite different. Therefore, we have
provided a narrative summary of each study and pre-
sented an overview of the available evidence.
Additional files
Additional file 1: MEDLINE Search Strategy. (DOCX 17 kb)
Additional file 2: Grey Literature Searches. (DOCX 15 kb)
Additional file 3: Excluded Studies. (DOCX 59 kb)
Abbreviations
3ie: International Initiative for Impact Evaluation; CBA: Controlled before-after stud-
ies; CIHR: Canadian Institutes of Health Research; COMMVAC: Communicate to
vaccinate; DfiD: Department for International Development; GRADE: Grading of
Recommendations Assessment, Development, and Evaluation; ICC: Intracluster
correlation coefficient; ITS: Interrupted time series; NGO: Non-governmental
organization; NRCT: Non-randomized controlled trial; RCT: Randomized controlled
trial; WHO: World Health Organization
Acknowledgements
The authors thank Christian Charbonneau who assisted with the screening
and data extraction.
Funding
This work is funded by JP’s CIHR Doctoral Research Award. The funder had
no role in the development of this protocol.
Availability of data and materials
The data extraction form available on request from the authors.
Authors’ contributions
JP, VW, and PT conceived the study. APA, HC, and MY developed, translated, and
ran the search strategy. MHJ and JP completed the screening and data extraction.
MHJ and JP summarized the results. JP wrote the first draft, and all authors revised
the manuscript. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable
Ethics approval and consent to participate
Not applicable
Author details
1University of Split School of Medicine, Split, Croatia. 2Bruyère Research
Institute, University of Ottawa, 43 Bruyère Street, Annex E room 302, Ottawa,
ON K1N 5C8, Canada. 3School of Epidemiology, Public Health and Preventive
Medicine, University of Ottawa, Ottawa, Canada. 4Gerstein Science
Information Centre, University of Toronto, Toronto, Canada. 5Department of
Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada. 6Ottawa
Hospital Research Institute, Clinical Epidemiology Program, Ottawa, Canada.
7Department of Epidemiology and Community Medicine, Faculty of
Medicine, University of Ottawa, Ottawa, Canada.
Received: 3 August 2016 Accepted: 2 December 2016
References
1. Welch V, Petticrew M, Tugwell P, Moher D, O’Neill J, et al. PRISMA-Equity
2012 Extension: reporting guidelines for systematic reviews with a focus on
health equity. PLoS Med. 2012;9:e1001333.
2. Lavis JN, Davies HT, Gruen RL, Walshe K, Farquhar CM. Working within and
beyond the Cochrane Collaboration to make systematic reviews more
useful to healthcare managers and policy makers. Healthc Policy. 2006;1:21–33.
3. Petticrew M, Whitehead M, Macintyre SJ, Graham H, Egan M. Evidence for
public health policy on inequalities: 1: the reality according to policymakers.
J Epidemiol Community Health. 2004;58:811–6.
4. Moat KA, Lavis JN, Abelson J. How contexts and issues influence the use
of policy-relevant research syntheses: a critical interpretive synthesis.
Milbank Q. 2013;91:604–48.
5. Rosenbaum SE, Glenton C, Wiysonge CS, Abalos E, Mignini L, Young T,
Althabe F, Ciapponi A, Marti SG, Meng Q, et al. Evidence summaries tailored
to health policy-makers in low- and middle-income countries. Bull World
Health Organ. 2011;89:54–61.
6. Kayabu B, Clarke M. The use of systematic reviews and other research
evidence in disasters and related areas: preliminary report of a needs
assessment survey. PLoS Curr Disasters. 2013. Edition 1. doi:10.1371/currents.
dis.ed42382881b3bf79478ad503be4693ea.
7. Adam T, Moat KA, Ghaffar A, Lavis JN. Towards a better understanding
of the nomenclature used in information-packaging efforts to support
evidence-informed policymaking in low- and middle-income countries.
Implement Sci. 2014;9:67.
8. Lavis J, Davies H, Oxman A, Denis JL, Golden-Biddle K, Ferlie E. Towards
systematic reviews that inform health care management and policy-making.
J Health Serv Res Policy. 2005;10 Suppl 1:35–48.
9. Murthy L, Shepperd S, Clarke MJ, Garner SE, Lavis JN, Perrier L, Roberts NW,
Straus SE. Interventions to improve the use of systematic reviews in
Petkovic et al. Implementation Science  (2016) 11:162 Page 13 of 14
decision-making by health system managers, policy makers and clinicians.
Cochrane Database Syst Rev. 2012;9:CD009401.
10. Perrier L, Mrklas K, Lavis JN, Straus SE. Interventions encouraging the use of
systematic reviews by health policymakers and managers: a systematic
review. Implement Sci. 2011;6:43.
11. Wallace J, Byrne C, Clarke M. Making evidence more wanted: a systematic
review of facilitators to enhance the uptake of evidence from systematic
reviews and meta-analyses. Int J Evid Based Healthc. 2012;10:338–46.
12. Oliver K, Innvar S, Lorenc T, Woodman J, Thomas J. A systematic review
of barriers to and facilitators of the use of evidence by policymakers.
BMC Health Serv Res. 2014;14:2.
13. Petkovic J, Welch V, Tugwell P. Do evidence summaries increase policy-
makers’ use of evidence from systematic reviews: a systematic review protocol.
Syst Rev. 2015;4:122.
14. Sampson M, McGowan J, Lefebvre C, Moher D, Grimshaw J. PRESS: Peer
Review of Electronic Search Strategies. Ottawa: Canadian Agency for Drugs
and Techonologies in Health; 2008.
15. Lavis JN, Posada FB, Haines A, Osei E. Use of research to inform public
policymaking. Lancet. 2004;364:1615–21.
16. Redman S, Turner T, Davies H, Williamson A, Haynes A, Brennan S, Milat A,
O’Connor D, Blyth F, Jorm L, Green S. The SPIRIT Action Framework: a
structured approach to selecting and testing strategies to increase the
use of research in policy. Soc Sci Med. 2015;136–137:147–55.
17. Amara N, Ouimet M, Landry R. New evidence on instrumental, conceptual,
and symbolic utilization of university research in government agencies.
Science Communication. 2004;26:75–106.
18. Cochrane handbook for systematic reviews of interventions. (Higgins JPT,
Green S eds.), vol. Version 5.1.0: The Cochrane Collaboration; 2011.
19. Ballini L, Bero L, Durieux P, Eccles MP, Grimshaw J, Gruen RL, Lewin S,
Mayhew A, Munabi-Babigumira S, O’Connor AD, et al. Cochrane effective
practice and organisation of care group. In: About The Cochrane Collaboration
(Cochrane Review Groups (CRGs). 2011.
20. Sterne JAC, Higgins JPT, Reeves BC. ACROBAT-NRSI obotdgf: A Cochrane
Risk of Bias Assessment Tool: for Non-Randomized Studies of Interventions
(ACROBAT-NRSI). 2014.
21. Wilson MG, Grimshaw JM, Haynes RB, Hanna SE, Raina P, Gruen R, Ouimet
M, Lavis JN. A process evaluation accompanying an attempted randomized
controlled trial of an evidence service for health system policymakers.
Health Res Policy Syst. 2015;13:78.
22. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Falck-Ytter Y,
Glasziou P, DeBeer H, et al. GRADE guidelines: 1. Introduction-GRADE evidence
profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383–94.
23. Brownson RC, Dodson EA, Stamatakis KA, Casey CM, Elliott MB, Luke DA,
Wintrode CG, Kreuter MW. Communicating evidence-based information
on cancer prevention to state-level policy makers. J Natl Cancer Inst.
2011;103:306–16.
24. What is a systematic review [http://www.campbellcollaboration.org/what_
is_a_systematic_review/index.php]. Accessed 3 Aug 2016.
25. Dobbins M, Hanna SE, Ciliska D, Manske S, Cameron R, Mercer SL, O’Mara L,
DeCorby K, Robeson P. A randomized controlled trial evaluating the impact
of knowledge translation and exchange strategies. Implement Sci. 2009;4:61.
26. Masset E, Gaarder M, Beynon P, Chapoy C. What is the impact of a policy
brief? Results of an experiment in research dissemination. Journal of
Development Effectiveness. 2013;5:50–63.
27. Opiyo N, Shepperd S, Musila N, Allen E, Nyamai R, Fretheim A, English M.
Comparison of alternative evidence summary and presentation formats
in clinical guideline development: a mixed-method study. PLoS ONE.
2013;8:e55067.
28. Vandvik PO, Santesso N, Akl EA, You J, Mulla S, Spencer FA, Johnston BC,
Brozek J, Kreis J, Brandt L, et al. Formatting modifications in GRADE evidence
profiles improved guideline panelists comprehension and accessibility to
information. A randomized trial. J Clin Epidemiol. 2012;65:748–55.
29. Beynon P, Chapoy C, Gaarder M, Masset E (Eds.): What difference does a policy
brief make? Full report of an IDS, 3ie, Norad study: Institute of Development
Studies and the International Initiative for Impact Evaluation (3ie); 2012.
30. Carrasco-Labra A, Brignardello-Petersen R, Santesso N, Neumann I, Mustafa RA,
Mbuagbaw L, Etxeandia Ikobaltzeta I, De Stio C, McCullagh LJ, Alonso-Coello P,
et al. Improving GRADE evidence tables part 1: a randomized trial shows
improved understanding of content in summary of findings tables with a
new format. J Clin Epidemiol. 2016;74:7–18.
31. Wilson MG, Lavis JN, Grimshaw JM, Haynes RB, Bekele T, Rourke SB. Effects
of an evidence service on community-based AIDS service organizations’
use of research evidence: a protocol for a randomized controlled trial.
Implement Sci. 2011;6:52.
32. Wilson PM, Farley K, Thompson C, Chambers D, Bickerdike L, Watt IS,
Lambert M, Turner R: Effects of a demand-led evidence briefing service
on the uptake and use of research evidence by commissioners of health
services: protocol for a controlled before and after study. Implementation Sci.
2015;10:7. doi:10.1186/s13012-014-0199-4.
33. Dobbins M, Jack S, Thomas H, Kothari A. Public health decision-makers’
informational needs and preferences for receiving research evidence.
Worldviews Evid Based Nurs. 2007;4:156–63.
34. Noor RA. Health research oversight in Africa. Acta Trop. 2009;112 Suppl 1:S63–70.
35. Perrier L, Persaud N, Thorpe KE, Straus SE. Using a systematic review
in clinical decision-making: a pilot parallel, randomized controlled trial.
Implement Sci. 2015;10:118.
36. Oermann MH, Roop JC, Nordstrom CK, Galvin EA, Floyd JA. Effectiveness of
an intervention for disseminating Cochrane reviews to nurses. Urol Nurs.
2009;29:35–9. 54.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Petkovic et al. Implementation Science  (2016) 11:162 Page 14 of 14
